Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.03 USD | +2.44% | +2.44% | +19.19% |
11:15am | Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US | MT |
May. 27 | Global markets live: UBS, Tesla, Nvidia, Apple, Micron... |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.19% | 292M | |
+8.92% | 114B | |
+10.48% | 105B | |
-6.45% | 23.83B | |
-3.61% | 21.73B | |
-10.28% | 18.1B | |
-42.36% | 16.34B | |
-14.45% | 16.13B | |
+3.76% | 13.75B | |
+28.94% | 11.76B |
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- Transcript : Vanda Pharmaceuticals Inc., Q4 2021 Earnings Call, Feb 23, 2022